On the Radar: Latest in nAMD Management in 2026 With Dr. Yasha Modi

Overview

Provider Statement

This continuing education activity is provided by

 

Support Statement

This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

Activity Description

In this podcast, expert faculty discuss durability-focused treatment strategies and long-term clinical data to optimize outcomes for patients with nAMD.

Target Audience

The intended audience for this activity is retina specialists, ophthalmologists, and optometrists involved in the management of retinal diseases.

Learning Objectives

Upon successful completion of this activity, participants should be better able to assess durability-focused treatment strategies and long-term clinical data to optimize outcomes for patients with nAMD.

Activity Chair

Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research
Director of Fellowship
Sierra Eye Associates
Clinical Professor of Surgery
University of Nevada, Reno School of Medicine
Reno, NV

Faculty

Yasha Modi, MD, MHS
Vice Chair of Ophthalmology
Manhattan Eye, Ear & Throat Hospital
Northwell Health
New York, NY

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

---

Accreditation

 In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

---

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

This enduring material is approved for 1 year from the date of original release, October 31, 2026, to October 30, 2027.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objective, answer the polling and pretest questions, listen to the podcast, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Arshad M. Khanani, MD, MA, FASRS

Consultant: 4DMT, AbbVie, ADARx, Adverum, Alcon, Alkeus, Allgenesis, Amgen, Annexin, Annexon, Apellis, Ashvattha, Astellas, Aviceda, Beacon, Boehringer Ingelheim, Complement Therapeutics, Entrada, Exegenesis, EyePoint, Frontera, Genentech, Harrow, i-Lumen, Kriya, Kyowa Kirin, Nanoscope, Neurotech, Novartis, Ocugen, Ocular Therapeutix, Oculis, Ollin, Opus, Perfuse, RecensMedical, Regeneron, Regenxbio, RevOpsis, Roche, Samsung, Sanofi, Stealth, Sun, Surrozen, Thea, Therini, Vanotech, ZipBio
Independent Research Contractor: 4DMT, AbbVie, ADARx, Adverum, Annexon, Astellas, Aviceda, Biojiva, Boehringer Ingelheim, Complement, Exegenesis, EyePoint, Genentech, Kyowa Kirin, Ocular Therapeutix, Ollin, ONL Therapeutics, Regenxbio, Roche, Sanofi, Vanotech
Stock Options: Ashvattha, Aviceda, Ollin, Perfuse, PolyPhotonix, RecensMedical, RevOpsis, ZipBio
Individual Stocks (publicly traded): Oculis

Yasha Modi, MD, MHS
Advisor: Adverum, Regeneron
Consultant: 4DMT, AbbVie, Alcon, EyePoint, Genentech

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Accessibility

Vindico Medical Education is committed to providing an inclusive learning environment and ensuring equitable access to our educational content. Our educational activities may include accessibility features, such as captioning, transcripts, reading aloud, and other platform-supported tools, to assist learners. Participants who require additional accommodation, alternative formats, or assistance accessing content are encouraged to contact us at CME@VindicoCME.com. Vindico will make all reasonable efforts to provide alternative formats in a timely manner.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2026 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at cme@vindicoCME.com